AorTech is focused on the commercialization of its world leading biomedical polymer technology, components and medical devices. It is listed on the UK London Stock Exchanges, Alternative Investment Market (AIM: AOR).
AorTech’s technologies have been designed to improve the performance and reliability of existing medical devices provide medical device designers with advantages and design options that were not available prior to the commercialization of our high performance polymer technologies.
Our business model is based on licensing our polymer technology to medical device companies. We then work as a partner with the device company to assist with their development programs resulting in a cost effective and rapid move to device registration and revenues. As part of this model, AorTech has sub-contracted manufacturing to a company who supplies polymers and/or can manufacture components for the partner